Publications | USF Parkinson's Disease and Movement Disorders Center

2005

Stacy, M, A Bowron, M Guttman, R Hauser, K Hughes, JP Larsen, P LeWitt, et al. 2005. “Identification of Motor and Nonmotor Wearing-off in Parkinson’s Disease: Comparison of a Patient Questionnaire versus a Clinician Assessment. Mov Disord 2005;20: 726-733.”. Mov Disord.

Zesiewicz, TA, J Sanchez-Ramos, KL Sullivan, and RA Hauser. 2005. “Levetiracetam-Induced Parkinsonism in a Huntington Disease Patient. Clin Neuropharmacol 2005;28:188-190.”. Clin Neuropharmacol.

Zesiewicz, TA, R Elble, ED Louis, RA Hauser, KL Sullivan, RB Dewey, and . 2005. “Quality Standards Subcommittee of the American Academy of Neurology. Practice Parameter: Therapies for Essential Tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology.”. Neurology.

Connors, JJ, D Sacks, AJ Furlan, WR Selman, EJ Russell, PE Stieg, MN Hadley, RA Hauser, and . 2005. “Training, Competency, and Credentialing Standards for Diagnostic Cervicocerebral Angiography, Carotid Stenting, and Cerebrovascular Intervention: A Joint Statement from the American Academy of Neurology. ”. Neurology.

2004

Hauser, RA, and K Lyons. 2004. “Future Treatments for Parkinson’s Disease. Neurol Clin 2004;22(Suppl 3):S149-166.”. Neurol Clin.

Olanow, CW, K Kieburtz, M Stern, R Watts, JW Langston, M Guarnieri, RA Hauser, and J Hubble. 2004. “Double-Blinded, Placebo-Controlled Study of Entacapone in Levodopa-Treated Patients With Parkinson Disease. Archives of Neurology, 61(10), 1563.”. Archives of Neurology.

Hauser, RA, F Deckers, and P Lehert. 2004. “Parkinson’s Disease Home Diary: Further Validation and Implications for Clinical Trials. Movement Disorders 2004;19:1409-1413.”. Movement Disorders.

Sullivan, KL, RA Hauser, and TA Zesiewicz. 2004. “Essential Tremor. Epidemiology, Diagnosis, and Treatment. Neurologist 2004;10:250-258.”. Neurologist.

Pahwa, R, K Lyons, and RA Hauser. 2004. “Ropinirole Therapy for Parkinson’s Disease. Expert Review of Neurotherapeutics 2004;4:581-588.”. Expert Review of Neurotherapeutics.

Zesiewicz, TA, W Stamey, KL Sullivan, and RA Hauser. 2004. “Botulinum Toxin A for the Treatment of Cervical Dystonia. Expert Opin Pharmacother 2004;5:2017-2024.”. Expert Opin Pharmcother.